The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

Trump directed a panel headed by HHS Secretary Robert F. Kennedy Jr. to assess “the prevalence of and threat” posed by SSRIs, ...

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

A recent review and meta-analysis of semaglutide studies found that this drug can significantly reduce the risk of ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

In this edition of The People's Pharmacy, Joe and Teresa Graedon also hear from a reader who's worried about using petroleum jelly.